---
title: "Aspire Biopharma to present at Life Sciences Virtual Investor Forum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290568880.md"
description: "Aspire Biopharma Holdings Inc. announced it will participate in the Life Sciences Virtual Investor Forum scheduled for June 24-25, 2026."
datetime: "2026-06-23T13:07:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290568880.md)
  - [en](https://longbridge.com/en/news/290568880.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290568880.md)
generator: "portal-rs"
---

# Aspire Biopharma to present at Life Sciences Virtual Investor Forum

-   Aspire Biopharma will participate in the Life Sciences Virtual Investor Forum on June 24-25, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ASBP.US](https://longbridge.com/en/quote/ASBP.US.md)
- [ASBPW.US](https://longbridge.com/en/quote/ASBPW.US.md)

## Related News & Research

- [Aspire Bi changes corporate name to Aspire-Lakewood Holdings; ticker ASBP unchanged](https://longbridge.com/en/news/298334577.md)
- [Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program  | ASBP Stock News](https://longbridge.com/en/news/298460655.md)
- [Aspire Biopharma posts August 2026 investor presentation on IR website](https://longbridge.com/en/news/298462129.md)
- [Damartex reports FY2025-26 annual results release available](https://longbridge.com/en/news/298344100.md)
- [Azenta files Form 3 for VP, Chief Accounting Officer Erik J. Bello](https://longbridge.com/en/news/298497736.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**